Skin problems common with anti-TNF

One in five inflammatory bowel disease patients suffer from skin complications when on anti-TNF therapy, according to French research.

The study, the first to investigate the incidence, management and outcomes of anti-TNF-induced dermatological conditions, involved almost 600 patients followed for up to 14 years.

Around 20% of patients developed a cutaneous adverse reaction, with a median follow-up of just over three